Skip to main content

People in the News: Dirk Evers, David Ghesquiere

Premium

Dirk Evers is VP of data operations at Molecular Health in Heidelberg, Germany. Previously, he was senior VP of informatics at the New York Genome Center and also served as the director of computational biology at Illumina. He holds a PhD in bioinformatics from Bielefeld University.


NanoString Technologies has appointed David Ghesquiere as senior VP of corporate and business development. Ghesquiere joins NanoString from Dendreon, where he served as senior VP of corporate and business development. He has also served executive roles with OSI Pharmaceuticals (acquired by Astellas) and Aventis Pharmaceuticals (acquired by Sanofi).

Filed under

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.